ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
600 hedge funds and large institutions have $26.2B invested in Alexion Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 242 increasing their positions, 209 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
1% more funds holding
Funds holding: 596 → 600 (+4)
11% less call options, than puts
Call options by funds: $308M | Put options by funds: $345M
Holders
600
Holding in Top 10
17
Calls
$308M
Puts
$345M
Top Buyers
| 1 | +$185M | |
| 2 | +$151M | |
| 3 | +$135M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$128M |
| 5 |
Swedbank
Stockholm,
Sweden
|
+$102M |
Top Sellers
| 1 | -$201M | |
| 2 | -$181M | |
| 3 | -$140M | |
| 4 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$114M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
-$109M |